Buy GE HealthCare: PCS Recovery + Heavy Orders Could Reignite Revenue After PDx Headwind
GE HealthCare's recent order momentum, improving Patient Care Solutions (PCS) recovery, and a deep innovation pipeline support a constructive trade. Valuation is reasonable - market cap ~$31.8B, P/E ~16, EV/EBITDA ~11 - and free cash flow generation ($1.578B) provides downside protection. I'll take a long position with a 180 trading-day horizon, si…